Jain: Interstate Commerce Could Unlock Next Growth Wave Post-Rescheduling

Rescheduling Opens Door to Cross-Border Trade

Moving cannabis to Schedule III removes the Controlled Substances Act barrier preventing interstate shipments, Jain said. Under current Schedule I classification, transporting cannabis across state lines remains a federal felony even where both origin and destination states have legalized. Rescheduling would allow federally licensed operators to move product between states, subject to state-level reciprocity agreements.

The Drug Enforcement Administration's rescheduling timeline remains uncertain. But industry operators are already modeling supply-chain scenarios that assume interstate commerce by late 2027. For full background on this story, see the CannIntel topic hub on DEA rescheduling.

The shift from fifty isolated markets to a national supply network would fundamentally revalue every asset in the sector, from cultivation facilities to distribution contracts.

MSO Consolidation and Economies of Scale

Multi-state operators would consolidate production in low-cost cultivation hubs once interstate trade is legal, Jain said. States with favorable climates and lower labor costs—such as Oklahoma, Michigan, and parts of California—would become export centers. High-cost markets like Massachusetts and Illinois would shift toward retail and distribution.

Key operational shifts Jain anticipates:

• Centralized processing and packaging in 3-5 regional hubs
• Closure of redundant cultivation facilities in expensive markets
• Standardized product SKUs across state lines to capture brand economies
• Vertical integration giving way to specialized supply-chain roles

This restructuring would mirror the alcohol industry's post-Prohibition evolution, when regional breweries and distilleries replaced thousands of local producers.

Tax Relief and Capital Access

Rescheduling to Schedule III would eliminate Internal Revenue Code Section 280E, which currently bars cannabis operators from deducting ordinary business expenses. Jain estimates that 280E repeal would improve EBITDA margins by 15-25 percentage points for most MSOs. Many unprofitable operators would flip to cash-flow positive overnight.

Improved margins and federal legal clarity would also open institutional capital markets. Investment banks and private equity firms currently sidelined by federal prohibition would enter the sector once rescheduling is finalized, Jain said, driving a wave of M&A and public-market liquidity.

The next signal: DEA Administrator Anne Milgram has indicated a final rescheduling rule could be published by Q4 2026, though legal challenges from prohibitionist states could delay implementation into 2027.